Frontline Advancements: Clinical Data Overview of Echelon-1 and Echelon-2

Join Caroline Behler, MD,, on May 1 at 6:30PM to review data from 2 pivotal trials assessing Adcetris+AVD vs ABVD in previously untreated Stage III/IV classical Hodgkin lymphoma (cHL), and Adcetris+CHP vs CHOP in previously untreated CD30-expressing peripheral T-cell lymphoma (PTCL).

Website:

mailto:rbelder@seagen.com